Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 4:33 pm Purchase |
2025-03-06 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 11,971,377 19.900% |
1,528,196 (+14.63%) |
Filing History |
| 2025-02-14 4:41 pm Purchase |
2024-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Paradigm BioCapital Advisors LP | 3,515,986 6.000% |
907,412 (+34.79%) |
Filing History |
| 2025-02-14 11:24 am Purchase |
2024-12-31 | 13G | Janux Therapeutics, Inc. JANX |
JANUS HENDERSON GROUP PLC JHG |
3,562,402 6.100% |
1,724,611 (+93.84%) |
Filing History |
| 2025-02-12 09:30 am Purchase |
2024-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Adage Capital Management L.P. | 3,061,750 5.310% |
3,061,750 (New Position) |
Filing History |
| 2024-11-14 4:24 pm Sale |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-4,579,818 (Position Closed) |
Filing History |
| 2024-11-14 4:17 pm Sale |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 1,021,403 2.000% |
-2,104,494 (-67.32%) |
Filing History |
| 2024-11-14 4:01 pm Purchase |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
Campbell David Alan | 2,644,622 4.800% |
99,547 (+3.91%) |
Filing History |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | Janux Therapeutics, Inc. JANX |
FMR CORP | 7,824,674 14.999% |
3,153,461 (+67.51%) |
Filing History |
| 2024-11-08 5:58 pm Sale |
2024-11-06 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 2,146,482 4.100% |
-1,943,836 (-47.52%) |
Filing History |
| 2024-11-04 4:05 pm Sale |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
Bregua Corp | 2,999,990 5.800% |
-830,267 (-21.68%) |
Filing History |
| 2024-10-25 5:28 pm Sale |
2024-10-23 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 4,090,318 7.800% |
-548,408 (-11.82%) |
Filing History |
| 2024-10-23 5:39 pm Purchase |
2024-10-16 | 13G | Janux Therapeutics, Inc. JANX |
Paradigm BioCapital Advisors LP | 2,608,574 5.000% |
2,608,574 (New Position) |
Filing History |
| 2024-10-22 4:17 pm Sale |
2024-10-18 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 10,443,181 19.990% |
-299,812 (-2.79%) |
Filing History |
| 2024-10-22 4:16 pm Sale |
2024-10-18 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 4,638,726 8.900% |
-1,983,341 (-29.95%) |
Filing History |
| 2024-09-16 9:41 pm Sale |
2024-09-12 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 6,622,067 12.700% |
-682,423 (-9.34%) |
Filing History |
| 2024-09-16 9:35 pm Purchase |
2024-09-12 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 10,742,993 19.990% |
149,598 (+1.41%) |
Filing History |
| 2024-08-09 4:09 pm Sale |
2024-07-31 | 13D | Janux Therapeutics, Inc. JANX |
ORBIMED ADVISORS LLC | 1,965,266 3.800% |
-684,198 (-25.82%) |
Filing History |
| 2024-06-05 7:28 pm Sale |
2024-06-03 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 7,304,490 14.100% |
-1,496,249 (-17.00%) |
Filing History |
| 2024-03-06 6:54 pm Purchase |
2024-03-04 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 10,593,395 19.990% |
1,922,751 (+22.18%) |
Filing History |
| 2024-03-04 8:07 pm Sale |
2024-02-29 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 8,800,739 17.100% |
-965,615 (-9.89%) |
Filing History |